Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer ; volume:31 ; number:7 ; day:13 ; month:6 ; year:2023 ; pages:1-9 ; date:7.2023
Supportive care in cancer ; 31, Heft 7 (13.6.2023), 1-9, 7.2023
- Urheber
-
Wang, Yufan
McCarthy, Alexandra L.
Tuffaha, Haitham
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-07819-y
- URN
-
urn:nbn:de:101:1-2023101811021593405374
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Yufan
- McCarthy, Alexandra L.
- Tuffaha, Haitham
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Cost–utility analysis of a palliative care program in Colombia
A self-supervised classification model for endometrial diseases
Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
Cost-utility analysis of real-time artificial intelligent-assisted colonoscopy in Italy
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Cost–utility analysis of a palliative care program in Colombia
A self-supervised classification model for endometrial diseases
Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
Cost-utility analysis of real-time artificial intelligent-assisted colonoscopy in Italy
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Cost–utility analysis of a palliative care program in Colombia
A self-supervised classification model for endometrial diseases
Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis